AB143423
Oligomycin A, ATP synthase inhibitor
Be the first to review this product! Submit a review
|
(2 Publications)
MW 791.1 Da, Purity >97%. Macrolide antibiotic. ATP synthase inhibitor. Blocks the proton channel (Fo subunit) to uncouple oxidative phosphorylation. Shows antitumor activity. Active in vivo.
1 Images
- Chemical Structure
Lab
Chemical Structure - Oligomycin A, ATP synthase inhibitor (AB143423)
2D chemical structure image of ab143423, Oligomycin A, ATP synthase inhibitor
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C
Storage information
The product can be stored for up to 12 months
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Cell communication and signaling : CCS 22:485 PubMed39390438
2024
Loss of mitochondrial Ca response and CaMKII/ERK activation by LRRK2 mutation correlate with impaired depolarization-induced mitophagy.
Applications
Unspecified application
Species
Unspecified reactive species
Eunice Eun-Seo Chang,Huifang Liu,Zoe Yuen-Kiu Choi,Yasine Malki,Steffi Xi-Yue Zhang,Shirley Yin-Yu Pang,Michelle Hiu-Wai Kung,David B Ramsden,Shu-Leong Ho,Philip Wing-Lok Ho
Developmental cell 58:2597-2613.e4 PubMed37673063
2023
Mitochondrial leak metabolism induces the Spemann-Mangold Organizer via Hif-1α in Xenopus.
Applications
Unspecified application
Species
Unspecified reactive species
Alexandra MacColl Garfinkel,Nelli Mnatsakanyan,Jeet H Patel,Andrea E Wills,Amy Shteyman,Peter J S Smith,Kambiz N Alavian,Elizabeth Ann Jonas,Mustafa K Khokha
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com